🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire Dijon
NCT05922085 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Swallowing disorders (SD) are particularly common after extubation in the ICU and may be associated with an increased risk of lung disease, increased length of hospital stay, and a higher risk of early reintubation. In contrast, early detection of SDs has been shown to be associated with a decrease in these complications. Thus, there is a need for rapid and reliable assessment of SDs in ICU patients before the withdrawal of mechanical ventilation. Videofluoroscopy (VFS) and nasofibroscopy (NF) are the gold standard examinations for diagnosing SD. However, these two examinations are not feasible in intubated patients. In this context, ultrasound appears to be a promising alternative to identify patients at risk of SD after extubation. This examination can be performed at the intubated patient's bedside and can be used evaluate the mobility of the structures involved in swallowing. Many

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patient: * Major (≥18) * On mechanical ventilation for at least 48 hours * Affiliated to national health insurance Exclusion Criteria: Patient: * Under legal protection (curatorship, guardianship, safeguard of justice) * Pregnant, parturient or breastfeeding woman * Refusal to participate by the patient or their proxy (or an immediate family member) * Cognitive disorders incompatible with the understanding of instructions * Previously diagnosed swallowing disorders * With a neurological condition at the origin of the SD (stroke, ALS...) * Treated for a lesion of the aerodigestive tract (by surgery, radiotherapy or radio-chemotherapy) * presence of wounds or dressings on the areas to be evaluated that prevent ultrasound measurements * Patient for whom a decision to limit or stop life support treatments has been taken collegially within the intensive care unit * With one or more contraindications to performing NF: * Anatomical features not compatible with NF: mainly deviation of the nasal septum. * Risk of significant otorhinolaryngological bleeding
💊

What it tests

  • Ultrasound
  • nasofibroscopie
📍

Where

1 site
Chu Dijon Bourgogne
Dijon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy